MEDIPRINT OPHTHALMICS
Live / Registered — Registered (as of 28 Mar 2023)
What this means for you
Registered since 28 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90754981
- Registration number
- 7013429
- Mark type
- Design + words
- Filed
- 04 Jun 2021
- Published for opposition
- 14 Jun 2022
- Registered
- 28 Mar 2023
- Attorney of record
- Glenn E. Davis
Goods and services
- Class 005 — Pharmaceuticals: Contact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination thereof
Owner
- MediPrint Ophthalmics, Inc., San Diego, CA, US
- MediPrint Ophthalmics, Inc., San Diego, CA, US
- MediPrint Ophthalmics, Inc., San Diego, CA, US
Prosecution history
- 28 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 24 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Dec 2022 — USE AMENDMENT FILED
- 30 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 09 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jun 2022 — PUBLISHED FOR OPPOSITION
- 25 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 May 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 09 May 2022 — ASSIGNED TO LIE
- 06 May 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER